Adidas will sell existing Yeezy items, donate some revenues

Adidas will sell existing Yeezy items, donate some revenues


Adidas will begin selling existing Yeezy products in late May.

Source: Adidas

Adidas said Friday that it will start selling Yeezy products later this month for the first time since it ended its relationship with rapper Ye in October.

The apparel company cut ties with Ye, formerly known as Kanye West, after he made a string of hateful, antisemitic comments. Adidas said it will donate a significant amount of revenues from the sale to at least two organizations that combat discrimination and hate, the Anti-Defamation League and the Philonise and Keeta Floyd Institute for Social Change. 

related investing news

Walmart shares rise slightly on higher full-year guidance. Here's how to play the stock

CNBC Pro

“Selling and donating was the preferred option among all organizations and stakeholders we spoke to,” Adidas CEO Bjorn Gulden said in a statement.

The ADL aims to fight antisemitism, while the organization run by family members of George Floyd works on criminal and social justice issues. Adidas said it has explored many options for what to do with existing inventory after it ended its partnership with Ye, and spoken with a diverse group of people about how to proceed.

“We believe this is the best solution as it respects the created designs and produced shoes, it works for our people, resolves an inventory problem, and will have a positive impact in our communities,” Gulden said. “There is no place in sport or society for hate of any kind and we remain committed to fighting against it.”

The products will only be available through the Adidas website and app.

Adidas said the move will have no immediate effect on its financial guidance for 2023. Adidas’ most recent earnings beat expectations, but were weighed down by Yeezy inventory piling up.

“The decline in lifestyle and the loss of Yeezy are of course hurting us,” Gulden said during his company’s earnings call earlier this month.

Prior to the split, Adidas had said their partnership with Yeezy was one of the most successful collaborations in the history of the industry.

In October, the Anti-Defamation League urged Adidas to sever ties with its leading endorser following his hateful remarks. The ADL praised the company’s move on Friday.

“At a time when antisemitism has reached historic levels in the U.S. and is rising globally, we appreciate how adidas turned a negative situation into a very positive outcome. They have shown real thoughtfulness in engaging with community organizations working to combat this pernicious and stubborn hatred,” said ADL CEO Jonathan Greenblatt.



Source

Value is the key to McDonald’s growth plans, but it’s creating tensions with some franchisees
Business

Value is the key to McDonald’s growth plans, but it’s creating tensions with some franchisees

The restaurant sector has spent the past 18 months trying to figure out how to reach consumers in a hypercompetitive and uneven economy. McDonald’s, which is set to report earnings after the bell Wednesday, has doubled down on value messaging to customers via Extra Value Meals and Snack Wraps, which will likely help to boost […]

Read More
Kraft Heinz pauses work to split the company as new CEO says ‘challenges are fixable’
Business

Kraft Heinz pauses work to split the company as new CEO says ‘challenges are fixable’

Kraft Heinz in September 2025 announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Kraft Heinz on Wednesday said that it is pausing work on its previously announced plans to split the company. Shares […]

Read More
Moderna says FDA refuses to review its application for experimental flu shot
Business

Moderna says FDA refuses to review its application for experimental flu shot

A researcher works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images The Food and Drug Administration has refused to start a review of Moderna‘s application for its experimental flu shot, the company announced Tuesday, in another sign of the […]

Read More